Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 60-66

  Holz Smith, S L ^a   Sun, I C ^a   Jin, L ^a   Matthews, T J ^a   Lee, K H ^a   Chin Ho Chen, ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (8 BETULINOYLAMINOOCTANOYLAMINO) 3 HYDROXY 6 METHYLHEPTANOIC ACID; ANTIVIRUS AGENT; BETULIC ACID; BETULINIC ACID DERIVATIVE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG POTENCY; DRUG SENSITIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENVELOPE; VIRUS INHIBITION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELL FUSION; CELLS, CULTURED; CLONING, MOLECULAR; DRUG RESISTANCE, MICROBIAL; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MUTAGENESIS; PHENOTYPE; T-LYMPHOCYTES; TRITERPENES;

EID: 0035170951     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.60-66.2001     Document Type: Article

References (44)

1. CC CKR5: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
2. Improved selectivity in the removal of the tert-butoxycarbonyl group
3. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320)
4. High efficiency transfection of primary human lymphocytes and studies of gene expression
5. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: A novel antiviral mechanism
6. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: Implication for viral fusion
7. Anti-AIDS agents, 6. Salaspermic acid, an anti-HIV principle from Tripterydium wilfordii, and the structure-activity correlation with its related compounds
8. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
9. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
10. Identification of a major co-receptor for primary isolates of HIV-1
11. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
12. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
13. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
14. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
15. Anti-AIDS agents, 11. Betulinic acid and platonic acid as anti-HIV activity of structurally related triterpenoids
16. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication
17. Anti-AIDS agents-XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives
18. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: A candidate for chemotherapeutic and microbicidal application
19. Anti-AIDS agents 15. Synthesis and anti-HIV activity of dihydroseselin-related compounds
20. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]
21. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein gp41
22. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents
23. A new convenient method for the esterification of carboxylic acids
24. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus
25. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
26. Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41
27. Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 env-mediated fusion depends on sequence and accessibility of the gp41 loop region
28. Anti-AIDS agents, 9. Suberosol, a new C31 lanostane-type triterpene and anti-HIV principle from Polyalthia suberosa
29. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells
30. Co-receptors for HIV-1 entry
31. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
32. A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modification
33. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
34. Pentacyclic triterpenes derived from Maprounea africana are potent inhibitors of HIV-1 reverse transcriptase
35. Generation of a neutralization resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene
36. Synthesis of (3S, 4S)-4-amino-3-hydroxy-6-methylheptanoic acid derivative. Analysis of diastereomeric purity
37. Determinants of human immunodeficiency virus type I resistance to gp41-derived inhibitory peptides
38. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding
39. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
40. Betulinic acid derivatives: A new class of specific inhibitors of human immunodeficiency virus type 1 entry
41. Anti-AIDS agents, 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents
42. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
43. Anti-HIV triterpene acids from Geum japonicum
44. Reduction of esters of carboxylic acids into aldehydes with diisobutylaluminum hydride